// COMPANY
Rhythm Pharmaceuticals
SECTOR BIOTECHMENTIONS 1LAST SEEN NOVEMBER 5, 2026
// RECENT MENTIONS
// SIGNALS
1 SIGNAL
01
m_and_a·Axios Pro Rata·NOVEMBER 5, 2026
“AstraZeneca last month offered to buy Rhythm Pharmaceuticals for around $10b, or $124 per share.”
AI-extracted from podcast / newsletter / paper summaries. May contain errors.